| Literature DB >> 28572516 |
Francesca Cingolani1, Fabio Simbari2, Jose Luis Abad2, Mireia Casasampere2, Gemma Fabrias2, Anthony H Futerman3, Josefina Casas4.
Abstract
Sphingolipids (SLs) have been extensively investigated in biomedical research due to their role as bioactive molecules in cells. Here, we describe the effect of a SL analog, jaspine B (JB), a cyclic anhydrophytosphingosine found in marine sponges, on the gastric cancer cell line, HGC-27. JB induced alterations in the sphingolipidome, mainly the accumulation of dihydrosphingosine, sphingosine, and their phosphorylated forms due to inhibition of ceramide synthases. Moreover, JB provoked atypical cell death in HGC-27 cells, characterized by the formation of cytoplasmic vacuoles in a time and dose-dependent manner. Vacuoles appeared to originate from macropinocytosis and triggered cytoplasmic disruption. The pan-caspase inhibitor, z-VAD, did not alter either cytotoxicity or vacuole formation, suggesting that JB activates a caspase-independent cell death mechanism. The autophagy inhibitor, wortmannin, did not decrease JB-stimulated LC3-II accumulation. In addition, cell vacuolation induced by JB was characterized by single-membrane vacuoles, which are different from double-membrane autophagosomes. These findings suggest that JB-induced cell vacuolation is not related to autophagy and it is also independent of its action on SL metabolism.Entities:
Keywords: anticancer drug; autophagy; liquid chromatography-mass spectrometry; methuosis; sphingolipid
Mesh:
Substances:
Year: 2017 PMID: 28572516 PMCID: PMC5538274 DOI: 10.1194/jlr.M072611
Source DB: PubMed Journal: J Lipid Res ISSN: 0022-2275 Impact factor: 5.922